glp 1 fast food makers warn GLP-1s will have 'lasting influence' on sector Fast food goes GLP-1: Shake

Tirzepatide and retatrutide are also glucose-dependent insulinotropic polypeptide (GIP) agonists

For many patients, the 1.7 mg dose delivers meaningful appetite suppression and weight management effects, making dose reduction a viable compromise

GLP-1 is the same hormone targeted by popular weight-loss medications like Ozempic and Wegovy

A few programs (notably Eden Health and SHED) offer both pathways through the same platform

These changes affect metabolism, muscle mass, and blood sugar response, which can make weight loss feel harder than it used to

GLP-1 RAs were not cost-effective at AU$28,000 per QALY under any scenario